Search Results
Search for other papers by Lena Lapkina-Gendler in
Google Scholar
PubMed
Search for other papers by Itai Rotem in
Google Scholar
PubMed
Search for other papers by Metsada Pasmanik-Chor in
Google Scholar
PubMed
Yoran Institute for Human Genome Research, Tel Aviv University, Tel Aviv, Israel
Search for other papers by David Gurwitz in
Google Scholar
PubMed
Search for other papers by Rive Sarfstein in
Google Scholar
PubMed
Search for other papers by Zvi Laron in
Google Scholar
PubMed
Yoran Institute for Human Genome Research, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Haim Werner in
Google Scholar
PubMed
al. 2005 ). The finding that the rate of cancer incidence in LS patients is very low is consistent with the notion that homozygous congenital IGF1 deficiency may confer protection against future development of a tumor. The present genome
Search for other papers by Zvi Laron in
Google Scholar
PubMed
Search for other papers by Haim Werner in
Google Scholar
PubMed
cancer protection. Classification of congenital IGF-1 deficiencies Prenatal IGF-1 expression is GH-independent though it becomes dependent on GH secretion shortly before birth ( Klammt et al . 2008 ). Hepatic IGF-1 biosynthesis remains dependent
Search for other papers by Serk In Park in
Google Scholar
PubMed
Department of Periodontics and Oral Medicine, Department of Pathology, University of Michigan School of Dentistry, 1011 North University Avenue, Ann Arbor, Michigan 48109, USA
Search for other papers by Laurie K McCauley in
Google Scholar
PubMed
), indicating a causal role of PTHrP in protection from anoikis. Figure 3 Ectopic expression of PTHrP rescued Ace-1 prostate cancer cells from anoikis. Ace-1 prostate cancer cells (expressing undetectable basal PTHrP) were engineered to express full-length PTHrP
Search for other papers by Jaesung (Peter) Choi in
Google Scholar
PubMed
Search for other papers by Reena Desai in
Google Scholar
PubMed
Search for other papers by Yu Zheng in
Google Scholar
PubMed
Search for other papers by Mu Yao in
Google Scholar
PubMed
Search for other papers by Qihan Dong in
Google Scholar
PubMed
Search for other papers by Geoff Watson in
Google Scholar
PubMed
Search for other papers by David J Handelsman in
Google Scholar
PubMed
Search for other papers by Ulla Simanainen in
Google Scholar
PubMed
, in prostate cancer cells, AR-mediated protection from PTEN induced apoptosis is independent of AKT pathway activation ( Li et al . 2001 ). In addition, our study showed diminished PTEN expression in the PTEN (OVX+testosterone) uterus compared to the
Instituto de Endocrinología IEMYR, Quito, Ecuador
Maastricht University, Maastricht, The Netherlands
Search for other papers by Jaime Guevara-Aguirre in
Google Scholar
PubMed
Search for other papers by Gabriela Peña in
Google Scholar
PubMed
Search for other papers by William Acosta in
Google Scholar
PubMed
Search for other papers by Gabriel Pazmiño in
Google Scholar
PubMed
Search for other papers by Jannette Saavedra in
Google Scholar
PubMed
Search for other papers by Lina Soto in
Google Scholar
PubMed
Search for other papers by Daniela Lescano in
Google Scholar
PubMed
Search for other papers by Alexandra Guevara in
Google Scholar
PubMed
Search for other papers by Antonio W D Gavilanes in
Google Scholar
PubMed
–24% cancer incidence ( Shevah & Laron 2007 ). Protection against cancer was not absolute, but malignancy incidence in IGFD individuals appeared diminished when compared to the non-IGFD relatives ( Aguiar-Oliveira et al. 2010 , 2017 , Steuerman et al
Search for other papers by Cesar Luiz Boguszewski in
Google Scholar
PubMed
Search for other papers by Margaret Cristina da Silva Boguszewski in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
that metastases could be suppressed after hypophysectomy led to treatment of advanced cancers in humans, particularly those of the breast and prostate, with surgical ablation of the pituitary, mainly in the 1950s and early1960s ( Bailey 1956 ). At that
Search for other papers by Cameron M Armstrong in
Google Scholar
PubMed
Search for other papers by Autumn R Billimek in
Google Scholar
PubMed
Search for other papers by Kimberly F Allred in
Google Scholar
PubMed
Search for other papers by Joseph M Sturino in
Google Scholar
PubMed
Search for other papers by Brad R Weeks in
Google Scholar
PubMed
Search for other papers by Clinton D Allred in
Google Scholar
PubMed
Introduction Women have a reduced risk of developing colon cancer when compared with men. This protection is lost, however, once a woman reaches menopause, suggesting estrogen is a protective agent against colon tumor development. Data from the
Search for other papers by J Riedemann in
Google Scholar
PubMed
Search for other papers by V M Macaulay in
Google Scholar
PubMed
that are currently being developed for blocking IGF1R action as anti-cancer therapy. Signalling through type 1 IGF receptor The IGF receptor family comprises three trans-membrane proteins. The IGF1R is a transmembrane receptor
Search for other papers by Courtney A Dreyer in
Google Scholar
PubMed
Search for other papers by Kacey VanderVorst in
Google Scholar
PubMed
Search for other papers by Savannah Free in
Google Scholar
PubMed
Search for other papers by Ashley Rowson-Hodel in
Google Scholar
PubMed
Search for other papers by Kermit L Carraway III in
Google Scholar
PubMed
Introduction Breast cancer metastasis Despite significant advances in the detection and treatment of breast tumors over the last few decades, metastatic disease remains the primary cause of breast cancer-related deaths ( Weigelt et al
Search for other papers by Giuseppe Palladino in
Google Scholar
PubMed
Search for other papers by Tiziana Notarangelo in
Google Scholar
PubMed
Search for other papers by Giuseppe Pannone in
Google Scholar
PubMed
Search for other papers by Annamaria Piscazzi in
Google Scholar
PubMed
Search for other papers by Olga Lamacchia in
Google Scholar
PubMed
Search for other papers by Lorenza Sisinni in
Google Scholar
PubMed
Search for other papers by Girolamo Spagnoletti in
Google Scholar
PubMed
Search for other papers by Paolo Toti in
Google Scholar
PubMed
Search for other papers by Angela Santoro in
Google Scholar
PubMed
Search for other papers by Giovanni Storto in
Google Scholar
PubMed
Search for other papers by Pantaleo Bufo in
Google Scholar
PubMed
Search for other papers by Mauro Cignarelli in
Google Scholar
PubMed
Search for other papers by Franca Esposito in
Google Scholar
PubMed
Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, Potenza, Italy
Search for other papers by Matteo Landriscina in
Google Scholar
PubMed
in prosurvival signaling of cancer cells, protection of mitochondria against oxidative stress, drug resistance, cell cycle regulation, metabolic reprogramming and regulation of protein homeostasis through the translational quality control of specific